Case number 1:24-cv-01089
Bristol-Myers Squibb Company et al v. Umedica Laboratories Pvt. Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 15, 2024 | 7 | NOTICE of Voluntary Dismissal by Bristol-Myers Squibb Company, Pfizer Inc. (Farnan, Michael) (Entered: 10/15/2024) (1) |
| Oct 15, 2024 | N/A | CASE CLOSED (jaa) (Entered: 04/25/2025) (0) |
| Oct 15, 2024 | 8 | Report to the Commissioner of Patents and Trademarks. (jaa) (Entered: 04/25/2025) (2) |
| Oct 2, 2024 | N/A | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 10/02/2024) (0) |
| Sep 30, 2024 | 1 | COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Umedica Laboratories Pvt. Ltd. ( Filing fee $ 405, receipt number ADEDC-4511721.) - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(cdd) (Entered: 09/30/2024) (0) |
| Sep 30, 2024 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cdd) (Entered: 09/30/2024) (3) |
| Sep 30, 2024 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/6/2024. Date of Expiration of Patent: 2/24/2031.Thirty Month Stay Deadline: 3/6/2027. (cdd) (Entered: 09/30/2024) (2) |
| Sep 30, 2024 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,326,945 B2. (cdd) (Entered: 09/30/2024) (1) |
| Sep 30, 2024 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Bristol-Myers Squibb Company, Pfizer Inc. (cdd) (Entered: 09/30/2024) (2) |
| Sep 30, 2024 | 6 | Summons Issued as to Umedica Laboratories Pvt. Ltd. on 9/30/2024. (cdd) (Entered: 09/30/2024) (2) |
